SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-000695
Filing Date
2023-01-09
Accepted
2023-01-09 07:27:37
Documents
16
Period of Report
2023-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20230108_8k.htm   iXBRL 8-K 40307
2 EXHIBIT 10.1 ex_462050.htm EX-10.1 11889
3 EXHIBIT 10.2 ex_462051.htm EX-10.2 68419
4 EXHIBIT 10.3 ex_462052.htm EX-10.3 50486
  Complete submission text file 0001437749-23-000695.txt   343009

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kmph-20230106.xsd EX-101.SCH 3601
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20230106_def.xml EX-101.DEF 11532
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20230106_lab.xml EX-101.LAB 15414
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20230106_pre.xml EX-101.PRE 11688
10 EXTRACTED XBRL INSTANCE DOCUMENT kmph20230108_8k_htm.xml XML 2553
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 23516567
SIC: 2834 Pharmaceutical Preparations